Epithalon · FOXO4-DRI · SS-31 — Ultimate Anti-Aging Protocol
The most comprehensive anti-aging peptide combination — addressing all three primary hallmarks of cellular aging simultaneously. Epithalon activates telomerase and restores pineal function, FOXO4-DRI eliminates accumulated senescent zombie cells, and SS-31 restores mitochondrial membrane integrity. Together they target aging at the genomic, cellular and organelle levels.
The Longevity Stack addresses aging at three distinct but interconnected biological levels — a more comprehensive approach than any single compound provides. Each component targets a different hallmark of cellular aging identified in the landmark Hallmarks of Aging framework.
Epithalon addresses aging at the genomic level through telomerase activation. As cells divide, telomeres shorten — when they reach critical length, cells enter senescence or die. Epithalon activates telomerase in somatic cells, extending telomere length and cellular replicative capacity. The compound also restores pineal melatonin production that declines with age, improving sleep quality, immune function and antioxidant protection. The 266-person human cohort study demonstrated 1.6–4.1x mortality reduction — the strongest anti-aging human data of any peptide available.
Even with telomere maintenance, cells that have already entered senescence remain as zombie cells releasing SASP inflammatory signals that drive tissue dysfunction. FOXO4-DRI specifically eliminates these accumulated senescent cells — clearing the inflammatory burden that accelerates aging in surrounding healthy tissue. Run quarterly, FOXO4-DRI keeps the senescent cell burden low and the tissue environment clean for healthy cell function.
Mitochondrial dysfunction is recognised as a primary driver of aging. SS-31 addresses this at the structural level — binding cardiolipin on the inner mitochondrial membrane, stabilising the electron transport chain complexes and reducing reactive oxygen species production at source. The result is improved ATP production, reduced oxidative damage throughout the cell, and restoration of the mitochondrial function that powers all cellular repair processes including those driven by Epithalon and FOXO4-DRI.
The three compounds are run on different schedules reflecting their distinct mechanisms. SS-31 is run continuously in 4-week on/2-week off cycles as a daily maintenance compound. Epithalon is run as 10-night courses 2-3 times per year to maintain telomere length and pineal function. FOXO4-DRI is run quarterly as a 3-day pulse to clear senescent cell accumulation. The combination provides year-round longevity support across all three biological levels.